Social consciousness about children that are vulnerable due to different diseases and involvement in such communities were deeply woven into the founding of EPPI. Our company had invested for over 10 years in Sarah’s Orphan Homes through Drugs for AIDS and HIV Patients.
EPPI also strongly believes that children are drug orphans in many disease states and the company has continued to develop drugs for orphan diseases such as HIV/AIDS and Sickle Cell Disease.
Medicines in the FDA pipeline: Pediatric HIV/AIDS drug products
HIV/AIDS
New Global Infections
|
 Ref: UNAIDS |
Sickle Cell Disease
Ref: American Society of Hematology |
 |
